Lansforsakringar Fondforvaltning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10M Sell
115,622
-4,351
-4% -$417K 0.05% 280
2025
Q4
$11.5M Buy
119,973
+112,331
+1,470% +$10.9M 0.06% 264
2025
Q3
$728K Sell
7,642
-158
-2% -$14.5K ﹤0.01% 509
2025
Q2
$680K Sell
7,800
-19,655
-72% -$1.67M ﹤0.01% 517
2025
Q1
$2.47M Sell
27,455
-5,076
-16% -$454K 0.02% 479
2024
Q4
$2.6M Buy
+32,531
New +$2.82M 0.01% 479

Other funds holding MDT

Lansforsakringar Fondforvaltning's MDT Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Medtronic (MDT) stake by 3.6% in Q1 2026, selling an estimated $417K and leaving 115,622 shares worth $10M. The position accounts for 0.05% of the portfolio, ranked #280.

Lansforsakringar Fondforvaltning first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.5M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 115,622 shares of Medtronic worth $10M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 4,351 Medtronic shares in Q1 2026, an estimated $417K.
  • Medtronic made up 0.05% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #280 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's Medtronic position peaked at $11.5M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.